VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹86 Cr | ₹37 Cr | ₹37 Cr | ₹41 Cr | ₹132 Cr |
What is the latest Cash Flow from Operating Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹37 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹132 Cr |
How is Cash Flow from Operating Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹86 Cr | 131.84 | |
| Mar2024 | ₹37 Cr | 1.80 | |
| Mar2023 | ₹37 Cr | -10.89 | |
| Mar2022 | ₹41 Cr | -68.82 | |
| Mar2021 | ₹132 Cr | - | |
Compare Cash Flow from Operating Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,245.9 Cr | -7.2% | -5.1% | 223.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -7.2% |
-5.1% |
223.6% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses